vidarabine has been researched along with Hepatitis B, Chronic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dumoulin, FL; Fischer, HP; Sauerbruch, T; Wasmuth, JC | 1 |
| Liu, W; Luo, C; Wan, JM; Zhao, W | 1 |
| Fried, MW; Sommadossi, JP | 1 |
| Lim, LC; Ng, HJ | 1 |
1 review(s) available for vidarabine and Hepatitis B, Chronic
| Article | Year |
|---|---|
Nucleoside analogues and other investigational modalities for the treatment of chronic hepatitis B.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Combined Modality Therapy; Dideoxynucleosides; Famciclovir; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Ribavirin; Vidarabine | 1996 |
3 other study(ies) available for vidarabine and Hepatitis B, Chronic
| Article | Year |
|---|---|
Fatal acute liver failure due to reactivation of hepatitis B following treatment with fludarabine/cyclophosphamide/rituximab for low grade non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Fatal Outcome; Hepatitis B, Chronic; Humans; Liver; Liver Failure, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Rituximab; Vidarabine | 2008 |
[The expression of HBsAg and HBcAg in the liver tissues of the patients with chronic hepatitis B before and after the treatment with arabinosyladenine].
Topics: Adult; Female; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Liver; Male; Middle Aged; Vidarabine | 2004 |
Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rituximab; Vidarabine; Virus Activation | 2001 |